Centers & Services

Neurology Department

What is the Neurology Department?

The Department of Neurology deals with stroke and dementia developing from lifestyle-related diseases or metabolic syndrome, headache, and Parkinson’s disease, which are expected to account for in creasing numbers of patients. In addition to them, the department targets neurodegenerative diseases or neuroimmune disease, and rehabilitation medicine, which are very important specialized fields in emergency medical services.

Our physicians

Koji Abe Professor
[Clinical neurology, cerebral vessel disorders, senile dementia, neurodegenerative diseases, neuroimmune diseases, peripheral nerve/muscular diseases]

Staff

Toru Yamashita Lecturer [Neurodegenerative diseases, ALS, dementia, stroke]
Yasuyuki Ohta Lecturer [Neurodegenerative diseases, ALS, PD, dementia, stroke]
Nozomi Hishikawa Assistant professor [Dementia]
Kota Sato Assistant professor [Neurodegenerative diseases, Parkinson's disease]
Mami Takemoto Assistant professor [Dementia]

*Specialty shown in [ ]

Weekly schedule of outpatient physicians

Monday Tuseday Wednesday Thursday Friday
Morning First-visiting Keiichiro Tsunoda Resident Koji Abe Professor Nozomi Hishikawa Assistant professor Taijyun Yunoki Resident Namiko Matsumoto Resident   Koji Abe Professor Noriko Hatanaka Resident Ryuta Morihara Resident Emi Nomura Resident
Specialized outpatient Michiaki Kitayama Lecturer Yuko Kawahara Resident (Immunology) Yasuyuki Ohta Lecturer(ALS/PD) Noriko Hatanaka Resident (Parkinson’s Disease) Mami Takemoto Assistant professor (Dementia) Yumiko Nakano (Stroke) Botulinus therapy outpatient Toru Yamashita Lecturer (SCD/Dementia) Nozomi Hishikawa Assistant professor (Dementia) Kouta Sato Assistant professor (Parkinson’s disease) Yoshiaki Takahashi Resident (Stroke)  

Treatment system

In the outpatient clinic service, specialists certified by the Japanese Society of Neurology and The Japan Stroke Society play a central role in providing medical treatment. In the inpatient ward, we hold conferences every week under the guidance of the specialists named above and also clarify points of inquiry that arise during professors’ rounds to provide the best intern ationally advanced treatments. The team, consisting of three departments of emergency medicine, neurological surgery, and neurology, responds to neurological critical care medicine on a round-the-clock basis, providing the latest treatments such as intravenous fibrinolytic therapy within the first three hours after the onset of stroke and performing well.

Treatment policy

Many patients, including those who are seeking a second opinion, have been referred to our department by numerous medical institutes throughout Japan including the Chugoku and Shikoku districts. Because our hospital plays a role of a core university hospital in Chugoku and Shikoku districts, we have organized the Sanyo Neurological Intractable Diseases Network and Sanyo Stroke Conference to provide medical support, life support, and work support for patients suffering from neurological intractable diseases or stroke through conferences and patient meetings, striving to contribute to community medical care.

Specialties

We have six specialized outpatient divisions, specifically administering treatments for stroke, dementia (Alzheimer disease), neurodegenerative diseases (amyotrophic lateral sclerosis, spinocerebellar degenerative disease, Parkinson’s disease , etc .) immune neurological diseases (multiple sclerosis, myasthenia gravis, CIDP, etc.) and botulinus therapy, to provide advanced and specialized treatments and to study the relation between lifestyle diseases and stroke/dementia as well.

Scope of target diseases

  • Stroke: responding to diseases such as cerebral infarction on a 24-hour basis.
  • Dementia diseases: such as Alzheimer disease
  • Neurodegenerative diseases: Parkinson’s diseases, spinocerebellar degenerative disease, amyotrophic lateral sclerosis, multiple system atrophy, etc.
  • Immune neurological diseases: myasthenia gravis, multiple sclerosis, autoimmune diseases, etc.
  • Peripheral nerve diseases: Guillain--Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), etc.
  • Infections of the nervous system: encephalomyelitis, meningitis, Creuzfeldt--Jakob disease, etc.
  • Myopathies: myositis, muscular dystrophy, etc.
  • Dynamic disorders: headache, neuralgia , epilepsia, facial spasm, spastic torticollis, etc. (Botulinus therapy is provided as a specialized outpatient service.)

Description of medical care

We make diagnoses of widely various diseases of brain, spinal cord, peripheral nerves, and muscles.
Particularly, we provide treatments for patients suffering from headache, numbness, dizziness, loss of memory, shaking of limbs, weakness/anesthesia of a limb, muscle atrophy, muscle ache, abnormality of gait, impaired tongue movement, cramps, etc.
As treatment service for typical diseases, we make precise diagnoses and provide appropriate drug therapy for migraines with notably advanced therapeutic agents.
In treatments for stroke, which are associated with lifestyle-related diseases and metabolic syndrome, we actively apply thrombolytic treatments with tissue plasminogen activator(t-PA) for hyperacute cerebral infarction and produce good results.
Furthermore, we perform the latest, evidence- based medication to prevent recurrence of cerebral infarction.
In terms of dementia, the patients of which will be increasing in number in the aging society , we use the latest treatment strategy for early diagnosis and treatment.
We have a great deal of experience in the following specialized neurological treatments: intravenous mmunoglobulin therapy for Guillain--Barre syndrome and chronic inflammatory demyelinating polyneuropathy(CIDP); interferon therapy for multiple sclerosis; immunological control therapy and plasma exchange therapy for myasthenia gravis; botulinum toxin therapy for blepharospasm, hemifacial spasm, and spastic torticollis.
Additionally, we actively work on treatments and life support activity for patients with different intractable neurological diseases.

For outpatients

(For information about first-visiting process, please refer to When you are referred to the hospital or the weekly schedule of outpatient physicians.)

For re-visiting outpatients
1) How to make an appointment: your appointment is accepted by the computer when your consultation is over.
2) Clinic hours for patients making an appointment in advance: they are described on the revised appointment schedule.

Highly advanced/specialized medical treatments

Techniques covered by health insurance programs

  • Genetic testing of genetic neurological disorders

Main methods for testing and explanation

  • Brain(function) diagnostic imaging: MRI, CT
    Functional brain imaging(cerebral blood flow scintigraphy, etc.), PET
  • Electrophysiological tests: brain wave, needle electromyography/nerve conduction velocity test, etc.
    Apnomonitor: examination of sleep apnea syndrome
  • Nerve/muscle biopsy: pathological examination of nerve and muscle
  • Respiratory function test, stab ilometer, sphygmograph, carotid echo, thermography, perspiration test, etc.
  • Examination of cerebrospinal fluid

Main testing methods and medical equipment

Electrophysiological tests

<Needle electromyography and nerve conduction velocity test>

These are useful to search for the responsible focus of numbness of face or a limb, paralysis, and amyotrophy and to ascertain the degree of severity and the state of recovery in the following diseases: neurodegenerative diseases such as amyotrophic lateral sclerosis; spinal diseases such as myelopathy and intervertebral dischernia; peripheral nerve disorders such as diabetic neurology, carpal tunnel syndrome, and facial nerve paralysis; muscle diseases such as myasthenia gravis and polymyositis.

<Evoked potential tests>

They are effective examinations to search for sites of organic lesions in neurological system and to ascertain the state of recovery using visual evoked potential , auditory brainstem response, somatosensory evoked potential, and magnetic stimulus.

<Brain wave>

Brain wave analysis is useful for the differentiation and diagnosis of epilepsia and disturbance of consciousness and judgment of treatment effects on them.

<Apnomonitor>

Screening tests of sleep apnea syndrome are useful for differentiation between central apnea and peripheral apnea and the judgment of treatment effects on them.

Different imaging tests

Imaging tests include MRI, MR angiography, CT, cerebral blood flow SPECT, and DAT-scan ning. They enable us to make comprehensive diagnoses and provide treatments.

Nerve/muscle biopsy

Pathological tests from biopsy are used to investigate the causes of muscle weakness, muscle atrophy, and disorder of sensation, which are useful in supporting treatment decisions.

Lumbar puncture

Lumbar puncture supports seful tests from samples of cerebrospinal fluid, enabling diagnoses of central nerve infections and other neurological diseases and to helping to define their treatment policies.

Genetic tests

They are effective to search for causes of heredity spinocerebellar degeneration, familial amyotrophic lateral sclerosis, muscular dystrophy, mitochondria encephalomyopathy, etc.

Botulinum toxin therapy for blepharospasm, hemifacial spasm, and spastic torticollis

This form of therapy is conducted by local injection of botulinum toxin.